TGR-1202 in Combination with Ibrutinib in Patients with Relapsed or Refractory CLL: Updated Results of a Multicenter Phase I/Ib Study

Drug Category: Array
Conference Category: Array
Lead Author: Davids M, et al.
Published Date: 15/05/2017
Download Link: /wp-content/uploads/2019/03/2017%20iwCLL%20TGR-1202%20Ibrutinib%20Davids.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top